Daniella Beckman has an estimated net worth of $3.44 Million. This is based on reported shares across multiple companies, which include Tango Therapeutics, Inc., Vor Biopharma Inc., Translate Bio, Inc., 5:01 Acquisition Corp., Blueprint Medicines Corp, IDENIX PHARMACEUTICALS INC, and Upstream Bio, Inc..

2024 was Daniella Beckman's most active year for acquiring shares with 6 total transactions. Daniella Beckman's most active month to acquire stocks was the month of May. 2014 was Daniella Beckman's most active year for disposing of shares, totalling 8 transactions. Daniella Beckman's most active month to dispose stocks was the month of July. 2025 saw Daniella Beckman paying a total of $499,924.24 for 233,830 shares, this is the most they've acquired in one year. In 2026 Daniella Beckman cashed out on 10,317 shares for a total of $126,530.86, their largest year based on trade value.